Evidence map›Paper›PMID 41684675›Full record

ReviewFrontiers in microbiology2026

Targeting vaginal dysbiosis: prospects for the application of live biotherapeutics products.

Qiongqiong Zhang, Xiaoxiao Zhao, Zhangran Chen, Rui Chen, Xiong Lin, Lei Zhang, Kangning Li, Min Wang, Yanmin Liu, Huan Zhou and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. The Gut-Vagina Axis.Microorganisms · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qiongqiong Zhang *Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.
Xiaoxiao Zhao *Shenzhen Wedge Microbiology Research Co., Ltd, Shenzhen, China.
Zhangran Chen *Shenzhen Wedge Microbiology Research Co., Ltd, Shenzhen, China.
Rui ChenDepartment of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.
Xiong LinShenzhen Wedge Microbiology Research Co., Ltd, Shenzhen, China.
Lei ZhangDepartment of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.
Kangning LiShenzhen Wedge Microbiology Research Co., Ltd, Shenzhen, China.
Min WangShenzhen Wedge Microbiology Research Co., Ltd, Shenzhen, China.
Yanmin LiuShenzhen Wedge Microbiology Research Co., Ltd, Shenzhen, China.
Huan ZhouShenzhen Wedge Microbiology Research Co., Ltd, Shenzhen, China.
Qinping LiaoDepartment of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a pivotal defense system within the female lower genital tract, the healthy vaginal microecosystem, dominated by

Indexed as

Lactobacilluslive biotherapeutics productsmicrobiota-based therapyvaginal dysbiosisvaginal microbiota

Identifiers

PMID41684675
PMCPMC12891168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.